Cargando…

Oncostatin M receptor is a novel therapeutic target in cervical squamous cell carcinoma

Cervical carcinoma is the second most common cause of cancer deaths in women worldwide. Treatments have not changed for decades and survival rates for advanced disease remain low. An exciting new molecular target for the treatment of cervical squamous cell carcinoma (SCC), and possibly for SCCs at o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Caffarel, Maria M, Coleman, Nicholas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Ltd 2014
Materias:	Invited Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4260121/ https://www.ncbi.nlm.nih.gov/pubmed/24659184 http://dx.doi.org/10.1002/path.4305

Ejemplares similares

Tissue transglutaminase mediates the pro-malignant effects of oncostatin M receptor over-expression in cervical squamous cell carcinoma
por: Caffarel, Maria M, et al.
Publicado: (2013)

Overexpression of the oncostatin-M receptor in cervical squamous cell carcinoma is associated with epithelial–mesenchymal transition and poor overall survival
por: Kucia-Tran, Justyna A, et al.
Publicado: (2016)

Multifaceted oncostatin M: novel roles and therapeutic potential of the oncostatin M signaling in rheumatoid arthritis
por: Han, Liang, et al.
Publicado: (2023)

Oncostatin M Receptor as a Therapeutic Target for Radioimmune Therapy in Synovial Sarcoma
por: McCollum, Sarah, et al.
Publicado: (2022)

Oncostatin M is overexpressed in skin squamous-cell carcinoma and promotes tumor progression
por: Simonneau, Marie, et al.
Publicado: (2018)

Oncostatin M: From Intracellular Signaling to Therapeutic Targets in Liver Cancer
por: Caligiuri, Alessandra, et al.
Publicado: (2022)

Promoter DNA Methylation of Oncostatin M receptor-β as a Novel Diagnostic and Therapeutic Marker in Colon Cancer
por: Kim, Myoung Sook, et al.
Publicado: (2009)

Stromal oncostatin M cytokine promotes breast cancer progression by reprogramming the tumor microenvironment
por: Araujo, Angela M., et al.
Publicado: (2022)

Stromal oncostatin M cytokine promotes breast cancer progression by reprogramming the tumor microenvironment
por: Araujo, Angela M., et al.
Publicado: (2022)

Towards developing a meaningful grading system for cervical squamous cell carcinoma
por: McCluggage, W Glenn
Publicado: (2018)

Oncostatin M Induction of Monocyte Chemoattractant Protein 1 is Inhibited by Anti-oncostatin M Receptor Beta Monoclonal Antibody KPL-716
por: RICHARDS, Carl D., et al.
Publicado: (2020)

The emerging world of subcellular biological medicine: extracellular vesicles as novel biomarkers, targets, and therapeutics
por: Coleman, Leon G.
Publicado: (2021)

Molecular Simulation of Oncostatin M and Receptor (OSM–OSMR) Interaction as a Potential Therapeutic Target for Inflammatory Bowel Disease
por: Du, Qingqing, et al.
Publicado: (2020)

A receptor fusion protein for the inhibition of murine oncostatin M
por: Brolund, Liv, et al.
Publicado: (2011)

The role of oncostatin M receptor gene polymorphisms in bladder cancer
por: Deng, Shi, et al.
Publicado: (2019)

Therapeutic potential of chemokine signal inhibition for metastatic breast cancer
por: Kitamura, Takanori, et al.
Publicado: (2015)

The novel mitochondria-targeted hydrogen sulfide (H(2)S) donors AP123 and AP39 protect against hyperglycemic injury in microvascular endothelial cells in vitro
por: Gerő, Domokos, et al.
Publicado: (2016)

Oncostatin M Modulation of Lipid Storage
por: Elks, Carrie M., et al.
Publicado: (2015)

Effects of arecoline on proliferation of oral squamous cell carcinoma cells by dysregulating c-Myc and miR-22, directly targeting oncostatin M
por: Chuerduangphui, Jureeporn, et al.
Publicado: (2018)

Invited Perspective: Risk of Bias Assessments, Target Trials, and the Strengths of Environmental Epidemiology
por: Huang, Jonathan
Publicado: (2023)

Invited Perspective: Measuring Biomarkers of Exposure in Target Organs—What Is Needed to Move Forward?
por: Hauser, Russ, et al.
Publicado: (2023)

The Enigmatic Cytokine Oncostatin M and Roles in Disease
por: Richards, Carl D.
Publicado: (2013)

Oncostatin M promotes lipolysis in white adipocytes
por: van Krieken, Pim P., et al.
Publicado: (2022)

A Novel Missense Mutation in Oncostatin M Receptor Beta Causing Primary Localized Cutaneous Amyloidosis
por: Saeedi, Marjan, et al.
Publicado: (2014)

The Role of Oncostatin M and Its Receptor Complexes in Cardiomyocyte Protection, Regeneration, and Failure
por: Kubin, Thomas, et al.
Publicado: (2022)

SRPK1 inhibition in prostate cancer: A novel anti-angiogenic treatment through modulation of VEGF alternative splicing
por: Mavrou, Athina, et al.
Publicado: (2016)

Oncostatin M was associated with thrombosis in patients with atrial fibrillation
por: Xie, Jun, et al.
Publicado: (2017)

Oncostatin M, an Underestimated Player in the Central Nervous System
por: Houben, Evelien, et al.
Publicado: (2019)

Role of oncostatin-M in ECM remodeling and plaque vulnerability
por: Patel, Parth, et al.
Publicado: (2023)

Ilex rotunda Thunb Protects Against Dextran Sulfate Sodium-Induced Ulcerative Colitis in Mice by Restoring the Intestinal Mucosal Barrier and Modulating the Oncostatin M/Oncostatin M Receptor Pathway
por: Li, Yao, et al.
Publicado: (2022)

Association of the Oncostatin M Receptor Gene Polymorphisms with Papillary Thyroid Cancer in the Korean Population
por: Hong, Il Ki, et al.
Publicado: (2011)

Essential roles of oncostatin M receptor β signaling in renal crystal formation in mice
por: Yamashita, Shimpei, et al.
Publicado: (2020)

Targeting De Novo Lipogenesis and Cholesterol Biosynthesis Simultaneously is a Novel Therapeutic Option for Hepatocellular Carcinoma
por: Liu, Qian, et al.
Publicado: (2021)

Targeting Angiogenesis in Squamous Cell Carcinoma of the Head and Neck: Opportunities in the Immunotherapy Era
por: Saba, Nabil F., et al.
Publicado: (2022)

Steroid hormone receptors and prostate cancer: role of structural dynamics in therapeutic targeting
por: Kumar, Raj
Publicado: (2016)

Novel nervous and multi-system regenerative therapeutic strategies for diabetes mellitus with mTOR
por: Maiese, Kenneth
Publicado: (2016)

WNT16 is Robustly Increased by Oncostatin M in Mouse Calvarial Osteoblasts and Acts as a Negative Feedback Regulator of Osteoclast Formation Induced by Oncostatin M
por: Henning, Petra, et al.
Publicado: (2021)

Oncostatin M is overexpressed in NASH‐related hepatocellular carcinoma and promotes cancer cell invasiveness and angiogenesis
por: Di Maira, Giovanni, et al.
Publicado: (2022)

Cell-specific mineralocorticoid receptors: future therapeutic targets for stroke?
por: Dinh, Quynh N., et al.
Publicado: (2016)

ULK1 as a novel therapeutic target in neurodegeneration
por: Vahsen, Björn Friedhelm, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ha87qufm1p5alcjpq8mg0sp79a